logo-loader
viewDarioHealth Corp.

Full interview: DarioHealth's digital diabetes app can demonstrate continuous improvement in diabetes patients

DarioHealth Corp. (NASDAQ:DRIO) Chief Commercial Officer Olivier Jarry tells Proactive the digital therapeutics company, which has 65,000 active users, is advancing its diabetes solutions and healthcare software application in the market, by showcasing its how its digital diabetes app demonstrates continues improvement in diabetes patients.

Jarry says what's more, the company is expanding its MyDario mobile app by moving into new chronic conditions and geographic markets, using a performance-based approach to improve the health of users managing chronic disease.

Quick facts: DarioHealth Corp.

Price: 6.05 USD

NASDAQ:DRIO
Market: NASDAQ
Market Cap: $18.76 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Parallax Health Sciences on an 'accelerated path' in its...

Parallax Health Sciences Inc (OTCPINK:PRLX) Chief Technology Office Nathaniel Bradley tells Proactive its subsidiary Parallax Diagnostics Inc is distributing vitamin D supplements to coronavirus medical and clinical services workers through a partnership with CURE Pharmaceutical Holding...

1 hour, 31 minutes ago

2 min read